These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 8553691)
1. Metabolism of a novel antiarrhythmic agent, bidisomide, in man: use of high resolution mass spectrometry to distinguish desisopropyl bidisomide from desacetyl bidisomide. Cook CS; Ames GB; Hribar JD; Liu NW; Sweeney DL; Schoenhard GL; Karim A Xenobiotica; 1995 Sep; 25(9):981-91. PubMed ID: 8553691 [TBL] [Abstract][Full Text] [Related]
2. Effect of diet and gavage on the dose- and dose-mode-dependent absorption and metabolism of bidisomide in rat. Cook CS; Lonien M; Hribar J Xenobiotica; 2000 May; 30(5):523-33. PubMed ID: 10875685 [TBL] [Abstract][Full Text] [Related]
3. Reduced systemic availability of an antiarrhythmic drug, bidisomide, with meal co-administration: relationship with region-dependent intestinal absorption. Pao LH; Zhou SY; Cook C; Kararli T; Kirchhoff C; Truelove J; Karim A; Fleisher D Pharm Res; 1998 Feb; 15(2):221-7. PubMed ID: 9523307 [TBL] [Abstract][Full Text] [Related]
4. Metabolism of actisomide in the dog, monkey and man: a novel rearrangement of N-dealkylated metabolites. Cook CS; Rozek LF; Hribar J; Schoenhard GL; Karim A Eur J Drug Metab Pharmacokinet; 1992; 17(2):145-54. PubMed ID: 1425813 [TBL] [Abstract][Full Text] [Related]
5. Absorption and disposition of a new antiarrhythmic agent bidisomide in man. Cook CS; Ames GB; Smith ME; Kowalski KG; Karim A Pharm Res; 1993 Nov; 10(11):1675-82. PubMed ID: 8290484 [TBL] [Abstract][Full Text] [Related]
6. Effects of a new class I antiarrhythmic drug bidisomide on canine ventricular arrhythmia models. Zhenjiu W; Awaji T; Hirasawa A; Motomura S; Hashimoto K Mol Cell Biochem; 1993 Feb; 119(1-2):159-69. PubMed ID: 8455577 [TBL] [Abstract][Full Text] [Related]
7. Bidisomide (SC-40230), a new antiarrhythmic agent: initial study of tolerability and pharmacokinetics. Page RL; Wharton JM; Wilkinson WE; Friedman IM; Claypool WD; Karim A; Kowalski KG; McDonald SJ; Gardiner P; Pritchett EL Clin Pharmacol Ther; 1992 Apr; 51(4):371-8. PubMed ID: 1563207 [TBL] [Abstract][Full Text] [Related]
8. Rapid infusions of bidisomide or disopyramide in conscious dogs: effect of myocardial infarction on acute tolerability. Schmidt JJ; Frederick LG; Garthwaite SM J Cardiovasc Pharmacol; 1992 Aug; 20(2):236-50. PubMed ID: 1381015 [TBL] [Abstract][Full Text] [Related]
9. Treatment of atrial fibrillation and paroxysmal supraventricular tachycardia with bidisomide. The Atrial Fibrillation Investigation with Bidisomide (AFIB) Investigators. Circulation; 1997 Oct; 96(8):2625-32. PubMed ID: 9355903 [TBL] [Abstract][Full Text] [Related]
10. Mechanism of compound- and species-specific food effects of structurally related antiarrhythmic drugs, disopyramide and bidisomide. Cook CS; Zhang L; Osis J; Schoenhard GL; Karim A Pharm Res; 1998 Mar; 15(3):429-33. PubMed ID: 9563073 [TBL] [Abstract][Full Text] [Related]
11. Effect of folate supplementation on clinical chemistry and hematologic changes related to bidisomide administration in the rat. Vandenberghe Y; Masson M; Palate B; Roba J Drug Chem Toxicol; 1995 Nov; 18(4):235-70. PubMed ID: 8586020 [TBL] [Abstract][Full Text] [Related]
12. Mechanisms of food effects of structurally related antiarrhythmic drugs, disopyramide and bidisomide in the rat. Lee KH; Xu GX; Schoenhard GL; Cook CS Pharm Res; 1997 Aug; 14(8):1030-8. PubMed ID: 9279885 [TBL] [Abstract][Full Text] [Related]
13. Comparison of bidisomide, flecainide and dofetilide on action potential duration in isolated canine atria: effect of isoproterenol. Martin CL; Palomo MA; Mcmahon EG J Pharmacol Exp Ther; 1996 Jul; 278(1):154-62. PubMed ID: 8764346 [TBL] [Abstract][Full Text] [Related]
14. Electrophysiologic effects of an antiarrhythmic agent, bidisomide, on sodium current in isolated rat ventricular myocytes: comparison with mexiletine and disopyramide. Homma N; Tsujimoto G; Hashimoto K Jpn J Pharmacol; 2001 May; 86(1):23-31. PubMed ID: 11430469 [TBL] [Abstract][Full Text] [Related]
15. Importance of pharmacokinetic and physicochemical data in the discovery and development of novel anti-arrhythmic drugs. Cook CS; McDonald SJ; Karim A Xenobiotica; 1993 Nov; 23(11):1299-309. PubMed ID: 8310713 [TBL] [Abstract][Full Text] [Related]
16. The effect of bidisomide (SC-40230), a new class Ia/Ib antiarrhythmic agent, on defibrillation energy requirements in dogs with healed myocardial infarctions. Hackett AM; Gardiner P; Garthwaite SM Pacing Clin Electrophysiol; 1993 Feb; 16(2):317-26. PubMed ID: 7680461 [TBL] [Abstract][Full Text] [Related]
17. Excretion and biotransformation of ketanserin after oral and intravenous administration in rats and dogs. Meuldermans W; Hendrickx J; Lauwers W; Swysen E; Hurkmans R; Knaeps F; Woestenborghs R; Heykants J Drug Metab Dispos; 1984; 12(6):772-81. PubMed ID: 6150829 [TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of lorcainide in man: a new antiarrhythmic agent. Klotz U; Müller-Seydlitz P; Heimburg P Clin Pharmacokinet; 1978; 3(5):407-18. PubMed ID: 699462 [TBL] [Abstract][Full Text] [Related]
19. Metabolites of cardiac antiarrhythmic drugs: their clinical role. Kates RE Ann N Y Acad Sci; 1984; 432():75-89. PubMed ID: 6441496 [TBL] [Abstract][Full Text] [Related]
20. Effect of enzyme induction on the disposition of lorcainide in rats following intravenous and oral administration. Plänitz V; Jähnchen E Arzneimittelforschung; 1984; 34(6):669-71. PubMed ID: 6541487 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]